Article Details
Retrieved on: 2022-07-01 13:07:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WILMINGTON, Del., July 01, 2022--AstraZeneca presented data for IMFINZI® (durvalumab) combinations from the HIMALAYA and TOPAZ-1 Phase III trials ...
Article found on: www.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here